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Municipal wastewater
S1 S2 S3
Organic carbon availability 
110
The single-stage configuration included a single bioreactor (U) with operating volume of 6 L.
111
The three-stage configuration was designed according to principles presented by Plósz (2007) 112 and included three reactors in series (named S1, S2, S3) with a total operating volume of 6 L
113
(1.5 L for S1 and S2 and 3 L for S3). To limit O 2 penetration, reactors were continuously Table S5 ). Characterization of organic carbon in the influent wastewater was carried out 143 according to Roeleveld and van Loosdrecht (2002) . 
251
In the simplest model structure, pseudo-first-order degradation kinetics was used to describe 
262
The transformation of human metabolites and other fractions (Polesel et al., 2016 ) may lead to the formation of parent compounds and can be additionally described using pseudo-first-order kinetics (Eq. 4): formation and biotransformation were thus described using Eq. 5:
or, in case of only one major conjugated metabolite, using Eq. 6: 
291
In all cases, model calibration against experimental data in Batch 1 and 2 was performed using 292 the secant method embedded in Aquasim 2.1d (Reichert, 1998 
307
Surface-normalized NO X removal rates exhibited a significant decrease after 400 days of 308 operation (Table S2 ). This may be attributed to the reduced average influent loading of organic 
311
Reactor staging effectively determined a declining gradient of influent substrate loading from 312 S1 to S3 (Table S3) Table S5 . In the following sections, results will be thus presented 389 and discussed for the listed substances.
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19 Negligible (≤15%) or no removal was observed in the abiotic control experiment (Fig. S11) Batch 2) exhibited elimination as in Figure 3a , following pseudo-first-order kinetics (Eq. 3) 405 that were described by k bio .
406
Initial increase of aqueous concentration was observed for SMX, SDZ, DCF and MET ( could also be quantified during Batch 1 (Fig S6e-f) . Eq. 4 and 6 were thus simultaneously calibrated to AcSDZ and SDZ measurements, respectively, allowing for the estimation of k dec (Fig. 3d) .
431
Pseudo-first-order transformation kinetics was assumed for the two enantiomers, being 432 described by rate constants k bio,1 and k bio,2 (L gTSS -1 d -1 ). Biotransformation of ATN and CIT
433
was thus described according to Eq. 9 (Table 1) : 
451
In Batch 1, the highest rate constant values were estimated either for S1 or U (Fig. 4a) 
458
In Batch 2, the highest transformation rate constants were observed in S1 for all non- consideration was valid for surface-normalized biotransformation rate constants (Fig. S10) .
467
In analogy with our study, decreasing influent COD loading was found to negatively influence 
528
In the three-stage system, non-recalcitrant and non-retransformable compounds showed highest 529 removal efficiency in S1 ( 
557
The relationship between denitrification and biotransformation kinetics in S1, S2, S3 and U and successfully calibrated to describe observed removal kinetics.
608
• As compared to previous findings for nitrifying MBBR and denitrifying activated sludge, shown in reactor S1, exposed to the highest electron donor loading and availability.
618
• When considering all MBBRs, biotransformation rate constants of non-recalcitrant pharmaceuticals positively correlated with mean specific denitrification rates, maximum (Fig. 3a )
Biotransformation and retransformation ( Fig. 3b-c )
1+
*In case the pharmaceutical has only one known retransformable conjugate (SDZ and AcSDZ), the stoichiometry coefficient F should be used, being equivalent to the ratio of the molecular weight of parent (M LI ) and conjugated (M CJ ) pharmaceutical. 
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